1. Home
  2. PEPG vs REAL Comparison

PEPG vs REAL Comparison

Compare PEPG & REAL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PEPG
  • REAL
  • Stock Information
  • Founded
  • PEPG 2018
  • REAL 2011
  • Country
  • PEPG United States
  • REAL United States
  • Employees
  • PEPG N/A
  • REAL N/A
  • Industry
  • PEPG Biotechnology: Pharmaceutical Preparations
  • REAL Other Specialty Stores
  • Sector
  • PEPG Health Care
  • REAL Consumer Discretionary
  • Exchange
  • PEPG Nasdaq
  • REAL Nasdaq
  • Market Cap
  • PEPG 250.3M
  • REAL 295.1M
  • IPO Year
  • PEPG 2022
  • REAL 2019
  • Fundamental
  • Price
  • PEPG $4.32
  • REAL $4.48
  • Analyst Decision
  • PEPG Buy
  • REAL Buy
  • Analyst Count
  • PEPG 3
  • REAL 6
  • Target Price
  • PEPG $14.67
  • REAL $4.13
  • AVG Volume (30 Days)
  • PEPG 133.3K
  • REAL 2.7M
  • Earning Date
  • PEPG 11-07-2024
  • REAL 11-04-2024
  • Dividend Yield
  • PEPG N/A
  • REAL N/A
  • EPS Growth
  • PEPG N/A
  • REAL N/A
  • EPS
  • PEPG N/A
  • REAL N/A
  • Revenue
  • PEPG N/A
  • REAL $579,862,000.00
  • Revenue This Year
  • PEPG N/A
  • REAL $10.55
  • Revenue Next Year
  • PEPG N/A
  • REAL $8.32
  • P/E Ratio
  • PEPG N/A
  • REAL N/A
  • Revenue Growth
  • PEPG N/A
  • REAL 2.52
  • 52 Week Low
  • PEPG $4.00
  • REAL $1.52
  • 52 Week High
  • PEPG $19.30
  • REAL $4.64
  • Technical
  • Relative Strength Index (RSI)
  • PEPG 23.52
  • REAL 78.99
  • Support Level
  • PEPG $4.00
  • REAL $3.84
  • Resistance Level
  • PEPG $4.77
  • REAL $4.27
  • Average True Range (ATR)
  • PEPG 0.56
  • REAL 0.29
  • MACD
  • PEPG -0.05
  • REAL 0.08
  • Stochastic Oscillator
  • PEPG 9.14
  • REAL 93.94

About PEPG PepGen Inc.

PepGen Inc is a clinical-stage biotechnology company advancing the next generation of oligonucleotide therapeutics to transform the treatment of severe neuromuscular and neurologic diseases. The company has developed its Enhanced Delivery Oligonucleotide platform to improve the uptake and activity of conjugated oligonucleotide therapeutics. Its EDO peptides are engineered to optimize tissue penetration, cellular uptake, and nuclear delivery, and in preclinical studies, it is observed their ability to transport oligonucleotides into a broad range of target tissues, including smooth, skeletal, and cardiac muscle and the central nervous system. Its pipeline products are; PGN-EDO51, PGN-EDODM1, and others including PGN-EDO53 and PGN-EDO45.

About REAL The RealReal Inc.

The RealReal is the largest pure-play luxury resale platform in the us, generating $1.7 billion in 2023 gross merchandise volume and addressing a niche (personal luxury resale) that had previously been serviced by inefficient upscale boutiques and local pawn shops. The company generates revenue via consignment and first-party sales on its online marketplace, and through a small volume of direct sales. With a hands-on approach that actively sources inventory and authenticates every item on its platform, The RealReal is able to justify much higher take rates than peers, working out to roughly 34% of net merchandise value, which excludes returns, cancellations, and first-party sales.

Share on Social Networks: